[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-371110-105":59,"doc-detail-371110-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","a-combined-transcriptomic-epigenetic-and-functional-analysis-identifies-novel-biomarkers-in-breast-cancer","A combined transcriptomic, epigenetic, and functional analysis identifies novel biomarkers in breast cancer","","Breast cancer is a major cause of cancer-related mortality in women worldwide, making reliable molecular biomarkers and therapeutic targets essential for better early diagnosis and treatment. This study integrates bioinformatics with experimental validation to uncover and functionally test key hub genes driving breast cancer progression. Three GEO microarray datasets were analyzed for common DEGs, hub genes were identified through PPI network methods, and expression was confirmed by RT-qPCR. Methylation, survival, immune associations, and drug sensitivity were evaluated using multiple databases, followed by in vitro functional assays.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-combined-transcriptomic-epigenetic-and-functional-analysis-identifies-novel-biomarkers-in-breast-cancer/371110/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-combined-transcriptomic-epigenetic-and-functional-analysis-identifies-novel-biomarkers-in-breast-cancer/371110.png","ImageObject",300,407,{"name":92,"@type":93},"CatatanPagi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main purpose of this study on breast cancer?","Question",{"text":112,"@type":113},"To identify key hub genes involved in breast cancer progression and functionally validate them as potential biomarkers and therapeutic targets.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were candidate hub genes selected and analyzed?",{"text":117,"@type":113},"Three GEO microarray datasets were used to find differential expression genes common across datasets, then PPI network analysis identified hub genes via STRING/Cytoscape and CytoHubba.",{"name":119,"@type":110,"acceptedAnswer":120},"Which hub genes were validated and what were their observed effects?",{"text":121,"@type":113},"PPARG, LEP, CD36, and PLIN1 were consistently downregulated, showed higher promoter methylation, and overexpression reduced proliferation, colony formation, and migration in vitro.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},371110,1790567022,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090894170,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Gari etal. Hereditas (2026) 163:16 Hereditas  \n[https://doi.org/10.1186/s41065-025-00630-1](https://doi.org/10.1186/s41065-025-00630-1)  \nRESEARCH Open Access  \nA combined transcriptomic, epigenetic, and functional analysis identifies novel biomarkers in breast cancer  \nMamdooh Gari 1*, Bandar K. Baothman2, Khalid Gari3, Majid Alhomrani4,5, Haneen Alsehli6, Abdullah G. Bagarish3, Yasir Hameed7*, Mohammed Natto8, Heba Alkhatabi9,10, Adel Abuzenadah8, Sajjad Karim 10 and  \nJaudah Al-Maghrabi 11  \nAbstract  \nBackground Breast cancer is a leading cause of cancer-related mortality among women worldwide. Identifying reliable molecular biomarkers and therapeutic targets is crucial for improving early diagnosis and treatment strategies. This study aimed to identify and functionally validate key hub genes involved in breast cancer progression using an integrated bioinformatics and experimental approach.  \nMethodology Three microarray datasets (GSE42568, GSE29431, and GSE21422) were retrieved from the GEO database to identify differential ly expressed genes (DEGs) . DEGs common across datasets were subjected to PPI network analysis using STRING and Cytoscape, and hub genes were identified via CytoHubba. The expression of hub genes was validated using RT-qPCR in six breast cancer and five normal epithelial cell lines. Methylation status, survival correlation, immune associations, and drug sensitivity were assessed via GSCA, cBioPortal, OncoDB, and TISIDB. Functional assays, including cell proliferation, colony formation, and wound healing assays were performed following gene overexpression in MCF-7 and T47D cells.  \nResults Four hub genes (PPARG, LEP, CD36, and PLIN1) were consistently downregulated in breast cancer and showed higher promoter methylation. Their expression correlated with tumor progression, poor survival, immune infiltration, and drug sensitivity. Functional validation demonstrated that overexpression of each gene reduced proliferation, colony formation, and migration in vitro. Additionally, these genes exhibited subtype-specific immune interactions and drug response profiles, with PPARG emerging as a particularly strong therapeutic biomarker. Conclusion This study identified and experimentally validated four hub genes as potential biomarkers and therapeutic targets in breast cancer. Their expression is regulated by methylation and contributes to tumor progression and immune modulation, highlighting their clinical utility in precision oncology.  \nKeywords Breast cancer, Biomarkers, Bioinformatics, Methylation, Immune infiltration, Functional validation  \n*Correspondence: Mamdooh Gari[mgari@kau.edu.sa](mgari@kau.edu.sa)[ ](mgari@kau.edu.sa)Yasir Hameed  \nyasirhameed201 [1@gmail.com](1@gmail.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ([http://creativecommons.org/publicdomain/zero/1.0/](http://creativecommons.org/publicdomain/zero/1.0/)) applies to the data made available in this article, unless otherwise stated in a credit line to the data.  \nGari ","cbCaidYcsPVeQoCt","https://ap.wps.com/l/cbCaidYcsPVeQoCt","pdf",6693580,17,"English","# Abstract\n# Methodology\n# Results\n# Conclusion\n# Keywords\n# Introduction","[{\"question\":\"What is the main purpose of this study on breast cancer?\",\"answer\":\"To identify key hub genes involved in breast cancer progression and functionally validate them as potential biomarkers and therapeutic targets.\"},{\"question\":\"How were candidate hub genes selected and analyzed?\",\"answer\":\"Three GEO microarray datasets were used to find differential expression genes common across datasets, then PPI network analysis identified hub genes via STRING/Cytoscape and CytoHubba.\"},{\"question\":\"Which hub genes were validated and what were their observed effects?\",\"answer\":\"PPARG, LEP, CD36, and PLIN1 were consistently downregulated, showed higher promoter methylation, and overexpression reduced proliferation, colony formation, and migration in vitro.\"}]","A combined transcriptomic, epigenetic, and functional analysis identifies novel biomarkers in breast cancer | PDF",1790191272,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cdeae338ae1c1aea22f5c3defdd44e5f.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/448fa6c3d3d5881872ad14c929387fef.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dd7659772f2d46d339fa3dce4b00d888.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/661d754b618be8d6b70e328c0902ea14.webp",980,1306]